Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Lancet Respir Med. 2019 Nov 11;7(12):1027–1038. doi: 10.1016/S2213-2600(19)30365-0

Figure 2.

Figure 2.

Prevalence of pulmonary exacerbations since the prior study visit for SCV culture-negative subjects compared with SCV culture-positive subjects at study visits 1–7 (Visit 8, which included relatively few subjects, is omitted for clarity). The number of subjects per culture status is indicated below each study visit.